ebook Munafa Stock Market Course + Intraday & FNO calls  

       

500124 announcements Dr.reddy's announcements and dividends declared BSE

Dr.reddy's Complete list of announcements declared & dividend announcements by Dr.reddy's 500124

Dr.reddy's 500124 listed on BSE and deals in

Announcements and dividends declared by Dr.reddy's 500124

Stocks in news: ITC Hotels, Dr Reddy's, SBI Life, Hero MotoCorp, Vedanta
Markets traded volatile on Thursday, ending nearly unchanged after early gains were erased by profit-taking in heavyweight stocks. Analysts suggest a short-term consolidation phase is likely, with Nifty holding above 25,600 considered healthy. Several comp
Announcement as on 24 October 2025

Dr Reddy’s Q2 Preview: PAT may grow up to 11–18% YoY; revenue seen steady despite pricing pressure in US
Dr Reddy’s Laboratories is expected to post steady September-quarter earnings with 10–14% revenue growth led by India and Europe, though US pricing pressure and weaker product mix may compress margins. Brokerages project up to 18% YoY profit growth.
Announcement as on 23 October 2025

Sun Pharma, Cipla or Dr Reddy's: Which pharma major is most vulnerable to Trump's 100% tariff
President Trump's imposition of 100% tariffs on branded drugs has shaken Indian pharma companies, impacting stocks like Sun Pharma, Cipla, and Dr. Reddy's. With significant US revenue exposure, firms face potential earnings hits, especially if tariffs expa
Announcement as on 26 September 2025

Stocks in news: Glenmark Pharma, Adani Energy, Dr Reddy's, Tata Motors, Newgen Software
Markets declined due to global and domestic pressures, with the Nifty testing support at 25040. Glenmark Pharma partnered with Hengrui Pharma, while Adani Energy Solutions achieved 'Zero-Waste-to-Landfill' certification. Poly Medicure will acquire Citieffe
Announcement as on 25 September 2025

Indian drugmakers Dr Reddy's, Hetero to sell generic HIV prevention drug for a year
Indian drugmakers, Dr Reddy's and Hetero Labs, will offer generic HIV prevention drugs. The price will be around yearly from 2027. This initiative aims to broaden access in low- and middle-income countries. Unitaid, the Clinton Health Access Initiative
Announcement as on 24 September 2025

Announcements by Dr.reddy's first page | Next page | Prev page |

500124 Dr.reddy's current price & indicator signals

Moving Averages for Dr.reddy's

  • 5Day Average: 1292.83
  • 12Day Average: 1299.39
  • 20Day Average: 1297.64
  • 50Day Average: 1253.85
  • 100Day Average: 1253.16
  • 150Day Average: 1257.65
  • 200Day Average: 1263.85

500124 Indicators & signals

Indicator MACD (12,26,9)

1295.31, 1286.15, 13.5
Indicator MACD is in positive zone

Indicator ADX (14)

19.33, 18.22, 26.94
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 50
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 500124 Dr.reddy's are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
18 Wed Mar 2026 1294.25 1281.55 to 1299.20 0.87% 0.27 times
17 Tue Mar 2026 1283.10 1265.05 to 1291.65 0.63% 0.34 times
16 Mon Mar 2026 1275.05 1263.35 to 1296.25 -1.39% 0.9 times
13 Fri Mar 2026 1293.00 1281.25 to 1319.95 -1.95% 1.48 times
12 Thu Mar 2026 1318.75 1304.00 to 1336.30 -0.51% 0.85 times
11 Wed Mar 2026 1325.50 1313.70 to 1335.85 0.88% 1.45 times
10 Tue Mar 2026 1313.90 1281.90 to 1329.00 2.14% 0.81 times
09 Mon Mar 2026 1286.40 1274.35 to 1294.85 -1.34% 1.01 times
06 Fri Mar 2026 1303.90 1291.70 to 1319.50 -0.7% 1.03 times
05 Thu Mar 2026 1313.05 1291.20 to 1321.50 1.7% 1.01 times
04 Wed Mar 2026 1291.15 1256.05 to 1298.90 -0.27% 1.12 times
02 Mon Mar 2026 1294.65 1205.05 to 1299.00 0.58% 1.86 times

Videos related to: 500124 announcements Dr.reddy's announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

500124 announcements Dr.reddy's announcements and dividends declared BSE

 

Back to top